Tigermed

Tigermed (Stock Code: 300347.SZ/3347.HK) is a leading integrated biopharmaceutical R&D service platform in the industry, providing innovative R&D solutions across the entire lifecycle for the global pharmaceutical and medical device sectors. With a comprehensive service system and top-tier quality standards, we enhance R&D efficiency, reduce R&D risks, ensure high-quality delivery of research projects, and accelerate the marketization of pharmaceutical products, fulfilling our commitment to the industry and patients. Additionally, through over 100 subsidiaries covering various fields, we build an innovative ecosystem that empowers the entire industry chain, focusing on addressing the most challenging global health issues, meeting unmet patient needs, creating social value, and benefiting human health.